Acute Gastroenteritis Management in CKD Patients

Initial Management

• The American Journal of Kidney Diseases recommends immediate aggressive isotonic crystalloid resuscitation in CKD patients with acute gastroenteritis, with careful monitoring for AKI development and strict avoidance of nephrotoxic medications, particularly NSAIDs 1, 2

Fluid Resuscitation Strategy

• The American Journal of Kidney Diseases suggests using isotonic crystalloids as first-line therapy for volume expansion in CKD patients with acute gastroenteritis, as evidence strongly supports crystalloids over colloids 1
• The American Journal of Kidney Diseases recommends initiating aggressive IV fluid resuscitation immediately upon presentation with signs of volume depletion, and monitoring hemodynamic response closely to avoid fluid overload 1

Medication Management

• The Kidney International recommends temporarily discontinuing nephrotoxic and kidney-dependent medications during the acute gastroenteritis episode in CKD patients 2, 3
• The Nature Reviews Nephrology suggests holding ACE inhibitors/ARBs immediately in CKD patients with acute gastroenteritis, as they increase AKI risk when combined with volume depletion 3
• The Kidney International recommends discontinuing SGLT2 inhibitors temporarily during acute illness to prevent volume depletion complications 2
• The Nature Reviews Nephrology advises stopping diuretics in CKD patients with acute gastroenteritis, as they exacerbate volume depletion 3
• The Nature Reviews Nephrology and Kidney International recommend avoiding NSAIDs in CKD patients with acute gastroenteritis, as they increase AKI risk 3, 4

Monitoring Strategy

• The American Journal of Kidney Diseases and Kidney International recommend monitoring kidney function intensively during and after the acute episode in CKD patients with acute gastroenteritis 1, 2
• The Kidney International suggests checking serum creatinine, urea, and electrolytes daily during acute illness, and calculating eGFR to assess for AKI development 2

Common Pitfalls to Avoid

• The Nature Reviews Nephrology warns against continuing nephrotoxic medications in CKD patients with acute gastroenteritis, as the combination of volume depletion and nephrotoxins dramatically increases AKI risk 3
• The Kidney International advises against forgetting to restart protective medications after recovery, as failure to resume ACE inhibitors/ARBs and SGLT2 inhibitors causes harm 2
• The American Journal of Kidney Diseases recommends avoiding the use of colloids for resuscitation in CKD patients with acute gastroenteritis, as crystalloids are preferred 1

Follow-Up After Resolution

• The American Journal of Kidney Diseases recommends re-evaluating kidney function 3-7 days after acute episode resolution in CKD patients with acute gastroenteritis 1
• The Kidney International suggests resuming chronic CKD management, including RAS inhibitors, SGLT2 inhibitors, and other protective therapies, once clinical stability is achieved 2